Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
Ibarra-Sifuentes HR, Del Cueto-Aguilera , Gallegos-Arguijo DA, Castillo-Torres SA, Vera-Pineda R, Martnez-Granados RJ et al (2017) Levocarnitine decreases intradialytic hypotension episodes: a randomized controlled trial
Food Control 79 , 349355 (2017)
Sin embargo, su impacto ms consistente parece estar en la mejora del flujo sanguneo y la reduccin del dao muscular post-ejercicio, lo que puede acelerar la recuperacin
No FDA approval for any therapeutic peptide in musculoskeletal medicine